^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Cizzle Biotech

    i
    Other names: Cizzle Biotechnology PLC | Cizzle Biotechnology | Cizzle Biotech | Cizzle Biotechnology plc | CIZZLE BIOTECHNOLOGY
    Evidence

    News

    almost2years
    ProteoGenix and Cizzle Biotechnology collaboration forges new paths in early detection of lung cancer through innovative antibody development (Pressat)
    "ProteoGenix...in a landmark collaboration with Cizzle Biotechnology Holdings PLC...announces the successful development of new antibodies targeting the CIZ1B biomarker, which is closely associated with early-stage lung cancer."
    Licensing / partnership
    over2years
    Expansion of research agreement with the University of York for cancer diagnosis and therapy and update on progress to launch CIZ1B biomarker early stage lung cancer test (Cizzle Biotech Press Release)
    "Cizzle Biotechnology...is pleased to announce an expansion of its current research programme with the University of York to develop its CIZ1B biomarker technology for early stage cancer diagnosis, and other potential applications in cancer therapy. This follows significant progress in isolating additional new and specific monoclonal antibodies to the CIZ1B biomarker and incorporating these into a new high-throughput clinical diagnostic immunoassay platform. The recent developments meet key milestones to begin commercial clinical trials. The Company is now engaged in clinical trials design to support the validation and accreditation of the CIZ1B test prior to commercial launch."
    Licensing / partnership • New trial
    over3years
    CorePath Laboratories, Cizzle Biotechnology partner on lung cancer blood test (Genomeweb)
    "CorePath Laboratories announced...that it is partnering with UK-based Cizzle Biotechnology to develop and offer an early-stage lung cancer liquid biopsy test in the US...The agreement with Cizzle Biotechnology represents a significant opportunity to provide early and cost-effective lung cancer detection via a simple and quick blood test which will result in significant cost savings downstream, avoiding expensive treatment, hospital admissions and ultimately saving lives..."
    Licensing / partnership